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Abstract We report a three generation family in which five
members, three females and two males, demonstrate a 44 bp
deletion (1164–1207del44) in the MECP2 gene associated
with Rett syndrome, leading to a truncation of the C-terminus
of the protein. Two of the three females and both males do
not meet RTT criteria whereas the youngest female has
classic RTT. Both males demonstrated a clear pattern of
progressive involvement including dystonia. The transmitting
females do not demonstrate features of RTT as a result of
unbalanced X chromosome inactivation (XCI) and were only
identified as carriers following the evaluation of the affected
males and the girl with classic RTT. As such, accurate
assessment of the precise frequency of MECP2 mutations in
carrier females with mild cognitive impairment or borderline
cognitive function will be under-represented unless an
affected offspring is recognized. Strategies for accurate
diagnosis in such instances should be considered carefully.
Keywords MECP2.Mutation.Xchromosome
inactivation.Phenotype-genotype.Rettsyndrome.
Male.Dystonia
Introduction
Rett syndrome is a neurodevelopmental disorder, predom-
inantly appearing in young girls and first described in 1966
by Andreas Rett [1], and is characterized by cognitive
impairment, communication dysfunction, stereotypic move-
ment disorder, and growth failure. RTT has an incidence
varying from 0.43–0.71/10,000 females in France [2]t o
1.09/10,000 females in Australia [3]. Diagnosis is based on
consensus clinical criteria [4]. Mutations were identified in
the methyl-CpG-binding protein 2 gene (MECP2) in 1999
[5]. More recent reports indicates that approximately 95%
individuals meeting these criteria will have one of the more
than 200 mutations identified in MECP2 [6, 7]. Eight
common point mutations (60%), 3′ frameshift mutations
(8–10%), or large deletions (7–9%) account for the majority
of affected individuals [6–8]. Mutations may also be seen in
males and females who do not meet the RTT consensus
criteria [6, 9, 10].
In most instances (>99.9%), RTT is a sporadic disorder.
Nonetheless, recurrences within families may occur [11]. In
such families, the mother is the transmitting parent and, due
to favorable X-chromosome inactivation (XCI) of the
abnormal chromosome, does not demonstrate features of
RTT. In addition, males in these families tend to present
with a severe encephalopathy in infancy [12]. Few families
in which males demonstrate less severe involvement have
been described [13]. We have recently evaluated five
members, three females and two males, in a three generation
family, all of whom demonstrate a 44 bp deletion (1164–
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DOI 10.1007/s11689-009-9034-71207del44). This deletion occurs in a known mutation
‘hotspot’ and has been described previously in RettBase
(www.chw.edu.au) in more than thirty females in association
with several phenotypes including classic and atypical
(congenital variant, preserved speech variant, and forme
fruste) RTT and in at least one male variant. Similar
deletions beginning at nucleotide 1164 have been described
in another three individuals. In the present family, two of the
three females and both males do not meet RTT criteria
whereas the youngest female has classic RTT. This report
describes this family in detail and provides the molecular
underpinning for the variable clinical presentations. The two
older females demonstrate no evidence of progressive
features unlike the males who appear to be following a
course of progressive decline.
Family description
The family (Fig. 1) described below was evaluated as part
of the NIH-funded Rare Disease Natural History study
(registered at www.clinicaltrials.gov; #NCT00299312). The
protocol and consent form for this study have been
approved by the Institutional Review Board for the
University of Alabama at Birmingham. Each affected
family member has the same MECP2 mutation, which is
an intragenic deletion in exon 4, 1164–1207del44 that
causes a truncation of the protein in the C-terminal domain.
In individuals meeting consensus criteria for RTT, mutations
in this region have been associated with a less severe
phenotype. Each affected member had a complete evaluation
in accordance with the study protocol. All dataforms were
completed including two severity scales, the Clinical Severity
Score (CSS) and the Motor-Behavioral Assessment (MBA)
[7]. In our RTT natural history study, the mean values for
those with classic RTT (N=529) are CSS=23.5 and MBA=
50.5. For individuals with 3′ frameshift mutations leading to
a truncation of the C-terminus of the MeCP2 protein in our
natural history study (N=42), CSS=21.2 and MBA=49.2.
Family member I:2 is a 52 year old female for whom
limited developmental history is available. However, no
evidence of specific developmental delays or loss of
previously acquired skill is known. She does not meet any
RTT consensus criteria and only constipation of the
supportive criteria. In addition to the mutation in MECP2,
she has polycystic kidney disease and currently requires
hemodialysis. She completed education through junior high
school and is able to conduct activities of daily living.
Psychometric testing at the University of Michigan in 2005
revealed a full scale IQ of 59. She currently lives in a group
home in order to assist with her on-going medical
management. Her two sons, II:1 and II:4, are described as
being in good health. The former is regarded as having a
learning disability whereas the latter has no known medical
or neurodevelopmental problems. Neither of these males
has been examined directly. On assessment, her general
physical and neurological examinations were unremarkable.
Her CSS was 1 and MBA was 3 (low scores indicating
minimal severity).
Family member II:2 is a 25 year old female whose early
development was considered to be normal without regres-
sion of previously acquired skills. She completed junior
high school. She also does not meet any RTT consensus or
supportive criteria. However, she has a history of significant
behavioral problems related to poor judgment, disinhibition,
promiscuity, and compulsive prevarication (mythomania).
She has polycystic kidney disease as well. Although she can
manage her personal care, she has been unable to manage
activities associated with independent living or care for her
children adequately such that they were placed in foster care
and subsequently adopted. She currently resides in the group
home with her mother on whom she relies for emotional
support. When tested in early 2009, her full scale IQ was 61
(verbal: 66 and performance: 60). Adaptive behavior assess-
ment was extremely low at 58. On assessment, her general
physical and neurological examinations were unremarkable.
CSS was 1 and MBA score was 2.
Family member II:4 is a 23 year old male with
progressive neurodevelopmental problems. He was born at
term with no known problems. However, his development
was quite delayed. He rolled over at 5 months, but did not
come to sit or crawl until 24 months. He pulled to stand at
12 months and lost this at age 5 years, and he walked with
support at 36 months and lost this at age 11 years. He held a
bottle and reached for a toy at 10 months losing both at age
14 years. He transferred at 36 months, had a pincer grasp,
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Fig. 1 The family pedigree: The five individuals with MECP2
mutations are depicted in this three generation pedigree. The female
in generation I represented by the bulls-eye has cognitive delay and
lacks the clinical features of RTT; the female in generation II
represented by the checkerboard pattern has cognitive delay and
aberrant behavior and lacks the clinical features of RTT; the female in
generation III represented by the vertical stripes has typical features of
RTT; and both males have cognitive delay and a pattern of progressive
motor impairments that do not reflect the clinical features of RTT
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10 years. He cooed at 3 months and smiled at 5 months and
still does so. He babbled at 15 months and lost this at an
unknown age. He spoke in single words at 36 months, but
lost the ability to speak at age 7 years. He gestured and
pointed for wants at age 5 years and lost both at age
10 years. He fixed and followed at 5 months and followed a
command at an unknown age and retains both. He has always
liked being held and was never visually or aurally inattentive.
Seizures began at age 2 years, but are no longer present.
Breathholding was noted at 14 months. Hyperventilation has
never been present. Constipation and gastroesophageal reflux
have been a problem since age 3 years. At age 10 years, he
was noted to have repetitive hand flicking movements, but
these are no longer present and no other stereotypies typical
for RTT have been noted. Scoliosis was noted at age 7 years,
becoming severe at 13 years despite bracing. A feeding
gastrostomy was placed at age 15 years and a tracheostomy
was performed for ventilatory failure during sleep at age
18 years. He is now ventilator dependent although he will
breathe independently for a brief time. He was described as
hypotonic and ataxic during early childhood; dystonia and
increasedmuscletone(rigidity)havebeenprogressivelymore
severe since then, necessitating treatment with an intrathecal
baclofen pump at age 13. From age 13 to the present,
botulinum toxin, phenol injections, and orthopedic surgeries
were performed to address progressive dystonia and contrac-
tures. Recurrent torticollis has also recently been treated
with botulinum toxin. At present, he is alert, anxious, and
interactive with prolonged eye contact. Visual fixation and
following are normal. He neither verbalizes nor vocalizes
and has no stereotypic movements. His scoliosis is greater
than 60° with right scapular prominence and rotation to the
right. Muscle mass is reduced. Strength is normal and muscle
stretch reflexes could not be obtained. He has no purposeful
hand use and is non-ambulatory. He has marked dystonia of
his upper extremities and at the ankles; contractures are
present at the knees and ankles. Head circumference has
shown a mild deceleration in growth rate (10th to < 2nd
percentile) after age 5 months. While he has demonstrated a
pattern of progressive motor difficulties with evident regres-
sion, most skills were lost after age 5 years. CSS was 34 and
MBA score was 61. Overall, he does not fulfill the consensus
criteriafor RTT,but has displayedfeaturesatvarious pointsin
time such as stereotypic movements that are RTT-like.
Family member III:1 is an 8 year old male who is
following the same neurodevelopmental trajectory as his
uncle (II:3). Pregnancy, labor and delivery, and early
developmental progress were not regarded as remarkable.
However, by age 2 months deceleration in the rate of head
growth was noted. Early gross motor skills developed
appropriately but by age 6 years he could no longer come to
a sit and by 7 years could no longer crawl. He never pulled
to a stand or walked independently, but did learn to walk
with support and can still do so with significant help. Early
fine motor skills including reaching for a toy, transferring,
and finger feeding appeared to be on time; however,
feeding pattern was always abnormal and a pincer grasp
never developed. Cooing, babbling, and words never
appeared and while he was attentive, he never responded
to commands. Social interaction was always appropriate.
Seizures and periodic breathing have not occurred. He was
noted to have transient hand wringing and periodically rub
his nose in a repetitive fashion. He has not demonstrated a
regression of any previously acquired fine motor skills, but
has failed to progress. Head circumference has shown a
moderate deceleration in growth rate (50th to the 10th
percentile) after age 2 months. Since age 6, he has had
progressive bilateral tremors, dystonia of the left upper
extremity requiring botulinum toxin, and spasticity of the
femoral adductors requiring tenotomy. On assessment, he
was alert and interactive and gave good eye contact. He
vocalized, but did not verbalize. Breathing pattern was
normal. He did engage in rubbing his nose periodically. He
was hypotonic in his extremities and axial muscles.
Strength, bulk, and muscle stretch reflexes were normal.
He reached for objects with his right hand using a raking-
type grasp. He sat with support, but would not walk with
support. He had a variety of involuntary movements
including tremor, myoclonus, and severe dystonia of his
left upper extremity. While seated on a narrow base, he had
marked titubation. He responded appropriately to light
touch. His hands were cool, but his feet were warm. He has
a mild degree of scoliosis. CSS was 20 and MBA score was
40. Overall, he does not fulfill the consensus criteria for
RTT, but does have features such as stereotypic movements
that are RTT-like.
Family member III:2 is a 6 year old female who meets
RTT consensus criteria. She was born at term with no
known problems. Other than poor feeding initially, early
development was regarded as normal. She sat, crawled,
walked, and developed fine motor hand skills at appropriate
ages. She used single words by age 12 months and phrases
by 18 months. She did have a brief period of visual and
aural inattention between age 15 and 17 months. However,
at age 3 years she began to regress with respect to these
skills and at age 6 years demonstrated hand stereotypies
including hand squeezing and finger flicking. She has had
no seizures, periodic breathing, or bruxism, but constipation
has been a problem since age 2 years, self-abusive behavior
in the form of biting since age 3 years, and GE-reflux since
age 4 years. She has difficulty going to sleep and awakens
frequently throughout the night. On assessment, she was
alert and interactive with good eye contact. She smiled and
had intermittent laughter. She vocalized, but did not
verbalize and was noted to hold her breath briefly and
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ing on the left and patting herself on her body. Muscle tone,
bulk, strength, and muscle stretch reflexes were normal.
Gegenhalten was noted in the upper extremities. She
reached for objects with either hand using a pincer grasp.
Gait was performed reasonably well on a narrow base, but
was semi-purposeful as she would not follow specific
directions and tended to wander. She had a mild degree of
generalized tremor and significant truncal rocking while at
rest. Skin temperature and response to light touch were
normal. No scoliosis was noted. CSS was 14 and MBA
score was 27. In our natural history study, both scores
are well below the mean values (N=529; CSS=23.5 and
MBA=50.5) for those with classic RTT.
Molecular testing MECP2 molecular testing of each family
member identified the same 44 base pair deletion beginning
at nucleotide 1164 (1164–1207del44), This mutation is
predicted to lead to a frameshift in translation of MeCP2
beginning at lysine 408, followed by insertion of twelve
unrelated amino acids before encountering a termination
codon (pK408fs12X). Each female had testing for X-
chromosome inactivation (XCI) through the Greenwood
Genetic Center clinical diagnostic laboratory using standard
methodology for the androgen receptor locus. Family
member I:2 had 89:11 distribution, family member II:3
had 77:23 distribution, and family member III:2 had 59:41
distribution. The results correlate with the phenotype noted
in each female. The two older females with favorable XCI
do not meet criteria for RTT despite their inability to be
completely independent. The youngest female with random
XCI meets criteria for RTT and expresses a clinical severity
pattern that is less than the mean value for those in our
natural history study (N=42; CSS=21.2 and MBA=49.2)
with C-terminal truncations. No evidence for mosaicism or
X-chromosome aneuploidy was detected in the males.
Discussion
RTT is a genetic disorder whose occurrence is sporadic in
most individuals, more than 99.5% resulting from a de novo
mutation in MECP2. Extended family pedigrees of the type
described here are rare. As such, the present family
provides important insights into the varied effects of a
given mutation depending on gender and XCI. The specific
44 bp deletion in this family has been described previously
in females with classic and atypical RTT phenotypes. This
mutation occurs in a known ‘hotspot’ for deletions (8.8% in
the North American database of 1928 individuals) and may
confer milder involvement [7, 8]. As noted above, RettBase
lists individuals with both classic and milder (forme fruste
and preserved speech) RTT variants. In previously reported
multiplex families, the males have had a severe infantile
encephalopathy such that assessing the clinical progression
in them over an extended period was often not possible
[9, 10]. The lone male previously reported with this deletion
was described as manifesting RTT [14]. His mother carried
the same mutation, but was described as normal. Her XCI
testing revealed a 95:5 distribution. In the present family, the
opportunity to observe two generations of males with a
much milder phenotype has been quite revealing. Both males
demonstrated a clear pattern of progressive involvement
beginning with normal early development and subsequent
motor and language delays that became apparent after the
first six months followed by the onset of dystonia in mid-
childhood and in the older male, loss of motor skills,
progression of dystonia, and gradual increase in muscle tone
to rigidity and joint contractures at present. Although both
males do not fulfill diagnostic criteria for RTT, each has had
features seen in RTT in the form of deceleration in the rate of
head growth and transient presence of stereotypic hand
movements. Therefore, in the absence of a normal X
chromosome as in females with RTT, it is not surprising
that MECP2 mutations in males are likely to result in
progressive dysfunction.
In females, the transmitting parent (or parents as in this
pedigree), as a result of unbalanced XCI, is typically not
recognized until a daughter meeting criteria for RTT is
born. The present family presents an additional level of
complexity in that c-terminal mutations have been asso-
ciated with somewhat milder involvement. The most vexing
problem is that accurate assessment of the precise frequency
of MECP2 mutations is likely to be under-represented
among females with mild cognitive impairment or borderline
cognitive function unless an affected offspring is identified.
Strategies for accurate diagnosis in such instances should be
considered carefully.
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